They are transcriptionally similar to CD4+FOXP3+ T cells; and although they seem to be less potent than CD4+FOXP3+ Tregs they have been shown to be effective in models of GVHD and lupus (126, 127). This evidence concerns the gene CD4 and systemic lupus erythematosus.